Accessibility Menu

Purple Biotech

(NASDAQ) KTOV

Current PriceN/A
Market CapN/A
Since IPO (2015)-100%
5 Year-100%
1 Year-93%
1 Month-57%

Purple Biotech Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

-$26.30

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

N/A

KTOV News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Purple Biotech

Industry

Pharmaceuticals

Employees

10

CEO

Gil Efron, MBA, CPA

KTOV Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

0%

Return on Assets

0%

Earnings Yield

N/A

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$1.00M

Operating Income

$0.00

EBITDA

$178.00K

Operating Cash Flow

-$5.58M

Capital Expenditure

$0.00

Free Cash Flow

-$5.58M

Cash & ST Invst.

$4.39M

Total Debt

$0.00

Purple Biotech Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$0.06

+1.4%

Gross Margin

N/A

N/A

Market Cap

N/A

N/A

Market Cap/Employee

$0.38

N/A

Employees

10

N/A

Net Income

-$0.09

+0.2%

EBITDA

-$2.18

+1.6%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$5.75

-2.7%

Total Debt

$0.18

+1.3%

Accounts Receivable

N/A

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.18

+1.3%

Return on Assets

-104.76%

+10.1%

Return on Invested Capital

-85.29%

+2.3%

Free Cash Flow

-$3.07

+1.0%

Operating Cash Flow

-$3.07

+1.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,561.58+0.02%
^DJIDJI
$51,806.69+0.01%
^IXICNASDAQ
$26,652.12+0.03%
BTCBitcoin
$66,762.00+0.05%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$15.46+0.03%
NOKNokia
$14.82+0.00%
PAYOPayoneer Global
$7.03+0.04%
PATHUiPath
$10.79+0.02%

Questions About KTOV

What is the current price of Purple Biotech?

Purple Biotech is trading at N/A per share.

What is the 52-week range for Purple Biotech?

Over the past 52 weeks, Purple Biotech has traded between N/A and N/A.

How much debt does Purple Biotech have?

As of the most recent reporting period, Purple Biotech reported total debt of $184.00K.

How much cash does Purple Biotech have on hand?

Purple Biotech reported $5.57M in cash and cash equivalents in its most recent financial results.

What is Purple Biotech’s dividend yield?

Purple Biotech does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.